RT Journal Article
SR Electronic
T1 Spike protein antibodies mediate the apparent correlation between SARS-CoV-2 nucleocapsid antibodies and neutralization test results
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.08.21255143
DO 10.1101/2021.04.08.21255143
A1 Perkmann, Thomas
A1 Koller, Thomas
A1 Perkmann-Nagele, Nicole
A1 Klausberger, Miriam
A1 Duerkop, Mark
A1 Holzer, Barbara
A1 Hartmann, Boris
A1 Mucher, Patrick
A1 Radakovics, Astrid
A1 Ozsvar-Kozma, Maria
A1 Wagner, Oswald F
A1 Binder, Christoph J
A1 Haslacher, Helmuth
YR 2021
UL http://medrxiv.org/content/early/2021/04/11/2021.04.08.21255143.abstract
AB Objectives SARS-CoV-2 infection induces the formation of different antibodies. However, not all of which might prevent the virus from entering the cell, although their concentrations correlate with the titers of viral neutralization tests (NTs). Antibodies against the viral nucleocapsid (NC), e.g., can be classified as such. We aimed to prove the hypothesis that the apparent correlation between NC-antibody levels and NT-titers is mediated by simultaneously occurring antibodies against viral spike-protein components.Methods We included 64 individuals with previous SARS-CoV-2 infection (>14d after symptom onset). SARS-CoV-2 antibodies against the NC (Roche total antibody ECLIA, Abbott IgG CMIA) and spike-protein (Technozym RBD ELISA, DiaSorin S1/S2 CLIA) were measured, and neutralization tests were performed. The effect of spike-protein antibodies on the correlation between NC-antibodies and NT-titers was evaluated by partial correlation and mediation analyses.Results Both tested assays assessing antibodies against the NC correlated significantly with NT titers: Abbott ρ=0.742, P<0.0001; Roche ρ=0.365, P<0.01. However, when controlling the rank correlations for the presence of RBD or S1/S2 antibodies, correlation coefficients dropped to ρ=0.318/ρ=0.329 (P<0.05/P<0.01), respectively for Abbott and vanished for Roche. As a result, only a maximum of 11% of NT titer variability could be explained by NC-antibody levels.Conclusions Our data suggest that the apparent correlation between NC antibodies and NT titers is strongly mediated by co-occurring RBD antibody concentrations. To avoid falsely implied causal relationships, all correlation analyses of non-spike-associated antibody assays and neutralization assays should include a partial correlation analysis to exclude a possible mediator effect of spike-associated antibodies.Competing Interest StatementTechnozym RBD kits were kindly provided by the manufacturer (Technoclone). CJB is board member of Technoclone. The Department of Laboratory Medicine received financial compensations for advertising space at scientific symposia from Roche, Abbott, and DiaSorin, outside the submitted work.Funding StatementTechnozym RBD kits were kindly provided by the manufacturer (Technoclone). There was no specific funding for the present study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Samples were either left-over materials from the General Hospital Vienna or donated by convalescent donors giving written informed consent (EK 2011/404). This evaluation is part of a study which was reviewed and approved by the ethics committee of the Medical University of Vienna (EK 2257/2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be requested by interested researchers from the corresponding author.